Fortis Group Advisors LLC Has $842,000 Holdings in The Procter & Gamble Company (NYSE:PG)

Fortis Group Advisors LLC reduced its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 7.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,860 shares of the company’s stock after selling 387 shares during the period. Fortis Group Advisors LLC’s holdings in Procter & Gamble were worth $842,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PG. Acorn Creek Capital LLC increased its position in Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares during the period. Alera Investment Advisors LLC raised its stake in Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after buying an additional 60 shares during the last quarter. Hudson Value Partners LLC boosted its position in Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after acquiring an additional 60 shares during the last quarter. Traveka Wealth LLC grew its holdings in Procter & Gamble by 1.7% during the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after acquiring an additional 60 shares during the period. Finally, Fiduciary Alliance LLC raised its position in shares of Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after acquiring an additional 61 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock valued at $65,140,718 over the last ninety days. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Stock Performance

PG stock traded up $0.78 during midday trading on Tuesday, hitting $170.32. The company’s stock had a trading volume of 2,182,723 shares, compared to its average volume of 6,664,997. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The stock has a market cap of $401.98 billion, a price-to-earnings ratio of 27.71, a PEG ratio of 3.74 and a beta of 0.41. The stock’s 50-day moving average price is $171.82 and its 200 day moving average price is $167.33. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 EPS. On average, equities analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.36%. Procter & Gamble’s payout ratio is 65.69%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their target price on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. DA Davidson boosted their target price on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday. Finally, Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $177.00.

Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.